Bayzed Health Group Inc (HKG:2609)

Bayzed Health Group Statistics

Total Valuation

HKG:2609 has a market cap or net worth of HKD 6.55 billion. The enterprise value is 6.58 billion.

Market Cap	6.55B
Enterprise Value	6.58B

Important Dates

The last earnings date was Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2609 has 1.32 billion shares outstanding. The number of shares has increased by 5.91% in one year.

Current Share Class	1.32B
Shares Outstanding	1.32B
Shares Change (YoY)	+5.91%
Shares Change (QoQ)	-9.57%
Owned by Insiders (%)	51.75%
Owned by Institutions (%)	19.66%
Float	595.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.26
PB Ratio	3.63
P/TBV Ratio	9.07
P/FCF Ratio	31.17
P/OCF Ratio	26.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 50.90, with an EV/FCF ratio of 31.30.

EV / Earnings	-456.29
EV / Sales	5.28
EV / EBITDA	50.90
EV / EBIT	234.24
EV / FCF	31.30

Financial Position

The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.34.

Current Ratio	1.69
Quick Ratio	1.25
Debt / Equity	0.34
Debt / EBITDA	4.69
Debt / FCF	2.88
Interest Coverage	1.17

Financial Efficiency

Return on equity (ROE) is -0.62% and return on invested capital (ROIC) is -1.53%.

Return on Equity (ROE)	-0.62%
Return on Assets (ROA)	0.66%
Return on Invested Capital (ROIC)	-1.53%
Return on Capital Employed (ROCE)	1.35%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.47
Inventory Turnover	12.29

Taxes

In the past 12 months, HKG:2609 has paid 20.00 million in taxes.

Income Tax	20.00M
Effective Tax Rate	193.39%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.81
200-Day Moving Average	5.52
Relative Strength Index (RSI)	61.94
Average Volume (20 Days)	30,164,059

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2609 had revenue of HKD 1.25 billion and -14.42 million in losses. Loss per share was -0.01.

Revenue	1.25B
Gross Profit	212.34M
Operating Income	28.09M
Pretax Income	10.34M
Net Income	-14.42M
EBITDA	99.11M
EBIT	28.09M
Loss Per Share	-0.01

Balance Sheet

The company has 691.03 million in cash and 605.91 million in debt, with a net cash position of 85.12 million or 0.06 per share.

Cash & Cash Equivalents	691.03M
Total Debt	605.91M
Net Cash	85.12M
Net Cash Per Share	0.06
Equity (Book Value)	1.80B
Book Value Per Share	1.28
Working Capital	525.33M

Cash Flow

In the last 12 months, operating cash flow was 247.43 million and capital expenditures -37.21 million, giving a free cash flow of 210.21 million.

Operating Cash Flow	247.43M
Capital Expenditures	-37.21M
Depreciation & Amortization	73.14M
Net Borrowing	-215.31M
Free Cash Flow	210.21M
FCF Per Share	0.16

Margins

Gross margin is 17.04%, with operating and profit margins of 2.25% and -1.16%.

Gross Margin	17.04%
Operating Margin	2.25%
Pretax Margin	0.83%
Profit Margin	-1.16%
EBITDA Margin	7.95%
EBIT Margin	2.25%
FCF Margin	16.87%

Dividends & Yields

HKG:2609 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.91%
Shareholder Yield	-5.91%
Earnings Yield	-0.22%
FCF Yield	3.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5